|
1
|
GordonMD Global Investments
Beverely Hills,
California
|
$37.8M
|
–
|
–
|
–
|
|
|
2
|
Gilead Sciences
Foster City,
California
|
$36.8M
|
–
|
–
|
–
|
|
|
3
|
|
$27.9M
|
+$20M
|
+2,257,729
|
+257%
|
|
|
4
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$25.7M
|
-$2M
|
-225,000
|
-7%
|
|
|
5
|
AIGH Capital Management
Baltimore,
Maryland
|
$24.9M
|
+$7.06M
|
+795,797
|
+40%
|
|
|
6
|
Deerfield Management
New York
|
$17.8M
|
–
|
–
|
–
|
|
|
7
|
Vanguard Capital Management
Malvern,
Pennsylvania
|
$16.9M
|
+$1.01M
|
+114,109
|
+6%
|
|
|
8
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$10.6M
|
-$3.28M
|
-369,264
|
-24%
|
|
|
9
|
Geode Capital Management
Boston,
Massachusetts
|
$9.35M
|
+$5.55M
|
+625,604
|
+148%
|
|
|
10
|
Insight Holdings Group
New York
|
$8.81M
|
–
|
–
|
–
|
|
|
11
|
|
$8.75M
|
+$44.5K
|
+5,018
|
+0.5%
|
|
|
12
|
State Street
Boston,
Massachusetts
|
$8.75M
|
+$7.49M
|
+843,933
|
+610%
|
|
|
13
|
Propel Bio Management
Los Angeles,
California
|
$7.87M
|
+$2.12M
|
+238,777
|
+37%
|
|
|
14
|
Woodline Partners
San Francisco,
California
|
$7.53M
|
–
|
–
|
–
|
|
|
15
|
Millennium Management
New York
|
$5.7M
|
-$3.25M
|
-365,728
|
-36%
|
|
|
16
|
MBB Public Markets
Chicago,
Illinois
|
$5.47M
|
–
|
–
|
–
|
|
|
17
|
Adage Capital Partners
Boston,
Massachusetts
|
$4.46M
|
–
|
–
|
–
|
|
|
18
|
|
$4.18M
|
-$2.24M
|
-252,235
|
-35%
|
|
|
19
|
Wells Fargo
San Francisco,
California
|
$3.32M
|
+$2.3M
|
+258,610
|
+226%
|
|
|
20
|
UBS Group
Zurich,
Switzerland
|
$3.26M
|
-$747K
|
-84,176
|
-19%
|
|
|
21
|
|
$2.99M
|
+$1.09M
|
+122,320
|
+57%
|
|
|
22
|
Renaissance Technologies
New York
|
$2.98M
|
-$298K
|
-33,593
|
-9%
|
|
|
23
|
Charles Schwab
San Francisco,
California
|
$2.85M
|
+$964K
|
+108,578
|
+51%
|
|
|
24
|
Northern Trust
Chicago,
Illinois
|
$2.81M
|
+$2.11M
|
+237,312
|
+304%
|
|
|
25
|
BNP Paribas Financial Markets
Paris,
France
|
$2.77M
|
-$900K
|
-101,400
|
-25%
|
|
